- Corporate Officers - V
- Van Nostrand Robert L
Insider Trading History of Van Nostrand Robert L
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Van Nostrand Robert L since 2016.
This trader's CIK number is 1225198.
At the time of last reporting, Van Nostrand Robert L was the Officer of Sellas Life Sciences Group, Inc.. (stock ticker symbol SLS).
Also see all insider trading activities at Sellas Life Sciences Group, Inc..
Note that in the past
VAN NOSTRAND ROBERT L also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Achillion Pharmaceuticals Inc (ACHN) by Van Nostrand Robert L
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2019 | ACHN | 0 | $0 | 0 | $0 | 20,000 | $65,600 |
| 2018 | ACHN | 0 | $0 | 0 | $0 | 20,000 | $21,000 |
Yearly summary of insider trading at Intra-cellular Therapies, Inc. (ITCI) by Van Nostrand Robert L
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2024 | ITCI | 0 | $0 | 40,000 | $2,976,300 | 41,567 | $708,400 |
| 2023 | ITCI | 0 | $0 | 10,000 | $630,000 | 10,000 | $130,500 |
| 2022 | ITCI | 0 | $0 | 30,000 | $1,709,250 | 30,000 | $382,500 |
| 2017 | ITCI | 345 | $4,995 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Enumeral Biomedical Holdings, Inc. (ENUM) by Van Nostrand Robert L
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2016 | ENUM | 0 | $0 | 0 | $0 | 156,000 | $19,500 |
Yearly summary of insider trading at Sellas Life Sciences Group, Inc. (SLS) by Van Nostrand Robert L
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2025 | SLS | 10,000 | $14,800 | 0 | $0 | 0 | $0 |
Insider trading activities at 4 companies by Van Nostrand Robert L:
1. Achillion Pharmaceuticals Inc (ACHN)
2. Intra-cellular Therapies, Inc. (ITCI)
3. Enumeral Biomedical Holdings, Inc. (ENUM)
4. Sellas Life Sciences Group, Inc. (SLS)
Table 1. Insider trading of Achillion Pharmaceuticals Inc (ACHN) by Van Nostrand Robert L
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2019-12-18 | ACHN | Option Ex | 20,000 | 3.28 | 65,600 |
| 2018-12-14 | ACHN | Option Ex | 20,000 | 1.05 | 21,000 |
Table 2. Insider trading of Intra-cellular Therapies, Inc. (ITCI) by Van Nostrand Robert L
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2024-06-23 | ITCI | Option Ex | 1,567 | .00 | 0 |
| 2024-06-18 | ITCI | Option Ex | 20,000 | 16.86 | 337,200 |
| 2024-06-18 | ITCI | Sale | 20,000 | 75.89 | 1,517,800 |
| 2024-02-27 | ITCI | Option Ex | 20,000 | 18.56 | 371,200 |
| 2024-02-27 | ITCI | Sale | 20,000 | 72.92 | 1,458,500 |
| 2023-04-17 | ITCI | Option Ex | 10,000 | 13.05 | 130,500 |
| 2023-04-17 | ITCI | Sale | 10,000 | 63.00 | 630,000 |
| 2022-08-11 | ITCI | Sale | 30,000 | 56.98 | 1,709,250 |
| 2022-08-11 | ITCI | Option Ex | 30,000 | 12.75 | 382,500 |
| 2017-12-29 | ITCI | Buy | 345 | 14.48 | 4,995 |
Table 3. Insider trading of Enumeral Biomedical Holdings, Inc. (ENUM) by Van Nostrand Robert L
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2016-12-09 | ENUM | Option Ex | 156,000 | .12 | 19,500 |
Table 4. Insider trading of Sellas Life Sciences Group, Inc. (SLS) by Van Nostrand Robert L
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2025-06-12 | SLS | Buy | 10,000 | 1.48 | 14,800 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Van Nostrand Robert L
(Officer of Sellas Life Sciences Group, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.